CN117185925A - Preparation method of polysubstituted aryl carboxylate compound - Google Patents
Preparation method of polysubstituted aryl carboxylate compound Download PDFInfo
- Publication number
- CN117185925A CN117185925A CN202310458655.2A CN202310458655A CN117185925A CN 117185925 A CN117185925 A CN 117185925A CN 202310458655 A CN202310458655 A CN 202310458655A CN 117185925 A CN117185925 A CN 117185925A
- Authority
- CN
- China
- Prior art keywords
- compound
- nmr
- mhz
- aryl
- chcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 polysubstituted aryl carboxylate compound Chemical class 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000006243 chemical reaction Methods 0.000 claims abstract description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 13
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 claims abstract description 11
- 150000001503 aryl iodides Chemical class 0.000 claims abstract description 10
- 239000003960 organic solvent Substances 0.000 claims abstract description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 7
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000001336 alkenes Chemical class 0.000 claims abstract description 6
- BMAXQTDMWYDIJX-UHFFFAOYSA-N bicyclo[2.2.1]hept-2-ene-5-carbonitrile Chemical compound C1C2C(C#N)CC1C=C2 BMAXQTDMWYDIJX-UHFFFAOYSA-N 0.000 claims abstract description 6
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims abstract description 5
- 229910000024 caesium carbonate Inorganic materials 0.000 claims abstract description 5
- 239000011261 inert gas Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims abstract description 4
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 38
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 10
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims description 2
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000006491 4-t-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000001318 4-trifluoromethylbenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(F)(F)F 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 claims description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract description 7
- 238000006555 catalytic reaction Methods 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 229910052763 palladium Inorganic materials 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 238000005859 coupling reaction Methods 0.000 abstract description 2
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 abstract description 2
- 238000005580 one pot reaction Methods 0.000 abstract description 2
- 239000012450 pharmaceutical intermediate Substances 0.000 abstract description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 66
- 238000005481 NMR spectroscopy Methods 0.000 description 39
- 239000000758 substrate Substances 0.000 description 38
- 238000003818 flash chromatography Methods 0.000 description 34
- 238000012512 characterization method Methods 0.000 description 33
- 239000003208 petroleum Substances 0.000 description 33
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 31
- 239000003921 oil Substances 0.000 description 25
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000012230 colorless oil Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 125000004185 ester group Chemical group 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- XTEOJPUYZWEXFI-UHFFFAOYSA-N butyl n-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate Chemical compound S1C(CC(C)C)=CC(C=2C=CC(CN3C=NC=C3)=CC=2)=C1S(=O)(=O)NC(=O)OCCCC XTEOJPUYZWEXFI-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical compound C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 231100000086 high toxicity Toxicity 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- OOUGLTULBSNHNF-UHFFFAOYSA-N 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C=2N=C(ON=2)C=2C(=CC=CC=2)F)=C1 OOUGLTULBSNHNF-UHFFFAOYSA-N 0.000 description 1
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 1
- KCBAMQOKOLXLOX-BSZYMOERSA-N CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O Chemical compound CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)CCCCCCCCCCNCCCONC(=O)C4=C(C(=C(C=C4)F)F)NC5=C(C=C(C=C5)I)F)O KCBAMQOKOLXLOX-BSZYMOERSA-N 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229940126639 Compound 33 Drugs 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 241000195634 Dunaliella Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- KTBAIBUBSGVINZ-UHFFFAOYSA-N amorfrutin C Chemical compound COC1=C(CC=C(C)C)C(O)=C(C(O)=O)C(CCC=2C=CC=CC=2)=C1CC=C(C)C KTBAIBUBSGVINZ-UHFFFAOYSA-N 0.000 description 1
- 229930010820 amorfrutin C Natural products 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 125000005251 aryl acyl group Chemical group 0.000 description 1
- 229960003995 ataluren Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UYUUAUOYLFIRJG-UHFFFAOYSA-N tris(4-methoxyphenyl)phosphane Chemical group C1=CC(OC)=CC=C1P(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 UYUUAUOYLFIRJG-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention belongs to the technical field of synthesis of pharmaceutical intermediates, and particularly relates to a preparation method of a polysubstituted aryl carboxylate compound. Cesium carbonate, palladium acetate and tris (5-methoxy-1-indolyl) phosphine are replaced by nitrogen for three times, then an organic solvent is added, then aryl iodide, water, chloroformate, olefin and 2-cyano-5-norbornene are sequentially added, and the mixture reacts under the protection of inert gas, and after the reaction is finished, the organic solvent is removed and purified, so that the polysubstituted aryl carboxylate compound is obtained; the invention adopts chloroformate, aryl iodide and ethyl acrylate to carry out domino coupling reaction under the synergistic catalysis of palladium and norbornene, and the polysubstituted aryl carboxylate compound is obtained by a one-pot method.
Description
Technical Field
The invention belongs to the technical field of synthesis of pharmaceutical intermediates, and particularly relates to a preparation method of a polysubstituted aryl carboxylate compound.
Background
It is well known that polysubstituted aryl carboxylic acids and derivatives thereof are very important building blocks, which are widely used in various valuable active substances such as natural products, medicines, pesticides, pigments, fragrances and leather. For example, the bioactive medicine molecule molugin separated from the madder shows good anticancer effect clinically; amorfrutin C separated from Glycyrrhrizae radix is a natural substance for anti-diabetic treatment, and has effects in reducing blood sugar and relieving inflammation; ataluren can promote the read-through of stop codon, and can effectively treat Dunaliella muscular dystrophy and cystic fibrosis. Therefore, the rapid and efficient preparation of poly-substituted aryl carboxylic acids and derivatives thereof (particularly poly-substituted aryl carboxylic esters) has been one of the key research directions for workers in the field of synthesis.
(1) The traditional methods for preparing aryl carboxylic esters mainly comprise two methods, namely: is mainly prepared by an esterification reaction method of aryl carboxylic acid and alcohol under the catalysis of strong acid or by a method of using aryl acyl chloride and alcohol to act in strong alkali. However, the two methods need to use strong acid/alkali, the reaction conditions are severe, the requirements on equipment are high, the functional groups sensitive to the strong acid/alkali are not compatible, and only a single ester group can be introduced. (J. Otera et al, analysis 2009; pp 3-157)
(2) In 2009, fumitoshi Kakiuchi, using chloroformate as an esterification reagent, and introducing an ester group onto 7, 8-benzoquinoline under the action of a ruthenium catalyst, was successful in synthesizing various polysubstituted aromatic esters. However, this method requires the use of quinoline as a directing group and at present only alkyl esters, benzyl esters and phenyl esters are introduced, which are not mentioned. (Kakiuchi, F.et al, J.am. Chem. Soc.2009, 131, 2792)
(3) In 2012, the Shi Bingfeng group used carbon monoxide and alcohol as the ester group sources, and synthesized aryl carboxylic acid esters by palladium catalysis. The reaction is insensitive to oxygen, has wide application range of the substrate and has great potential in the later modification of complex molecules. However, the method also uses pyridine as a guiding group, and the reagent has high toxicity, inconvenient operation and lack of environmental friendliness. (F. B.Shi et al, org. Biomol. Chem.,2014, 12, 2538)
(4) The problem of Dong Anbin in 2016 is that a self-made mixed anhydride is used as an electrophile, a sterically hindered ester group is used as a leaving group, and selective cleavage of a C-O bond is realized through Pd/NBE synergic catalysis, so that a polysubstituted aryl carboxylic acid derivative is obtained. Although this method exhibits a broad substrate range and high functional group compatibility, the atom economy is not high. (Dong, G.et al, chem.2016,1, 581-591)
Although there are many synthetic routes to synthesize aryl carboxylates, the reaction conditions are severe, directing groups are required, reagents are highly toxic, only one group can be singly introduced, and the atom economy is not high, so that the application of the reaction is greatly limited. Therefore, it is necessary to develop a novel method for synthesizing a polysubstituted aryl carboxylate compound with high atom economy.
Disclosure of Invention
The invention aims to solve the defects in the prior art and provides a preparation method of a polysubstituted aryl carboxylic ester compound, which adopts the following technical scheme:
a preparation method of a polysubstituted aryl carboxylic ester compound specifically comprises the following steps:
cesium carbonate, palladium acetate and tris (5-methoxy-1-indolyl) phosphine are added with an organic solvent after nitrogen is replaced for three times, then aryl iodide, water, chloroformate, olefin and 2-cyano-5-norbornene are sequentially added, and the mixture is reacted under the protection of inert gas for 12 h-48 h, and after the reaction is finished, the organic solvent is removed and the mixture is purified to obtain a polysubstituted aryl carboxylate compound; the structural formula of the aryl iodide is shown as formula I; the structural formula of the polysubstituted aryl carboxylic ester compound is shown as a formula II;
a formula I; />A formula II; wherein R is 1 ,R 2 Are each independently selected from aryl or alkyl.
The invention adopts chloroformate, aryl iodide and ethyl acrylate to carry out domino coupling reaction under the synergistic catalysis of palladium and norbornene to obtain the polysubstituted aryl carboxylate compound by a one-pot method, and solves the defects of high toxicity of reaction raw materials, low raw material utilization rate, harsh reaction conditions and the like in the prior art.
As a further preferred embodiment, R 1 At least one selected from methyl, ethyl, isopropyl, phenyl, oxytrifluoromethyl, methoxy, trifluoromethyl, halogen, nitro and alkoxycarbonyl.
As a further preferred embodiment, R 2 Selected from butyl, heptyl, isopropyl, sec-butyl, isobutyl, cyclopentyl, 9-fluorenylmethoxycarbonyl, [1S- (1. Alpha., 2. Alpha., 5. Beta.)]-at least one of 5-methyl-2- (1-methylethyl) cyclohexyl, benzyl, 4-fluorobenzyl, 4-trifluoromethylbenzyl, 2-chlorobenzyl, 4-cyanobenzyl, 4-nitrobenzyl, 4-methoxybenzyl, 4-t-butylbenzyl.
As a further preferred embodiment, the molar ratio of aryl iodide species, cesium carbonate, palladium acetate, tris (5-methoxy-1-indolyl) phosphine, water, chloroformate, alkene and 2-cyano-5-norbornene is 1:3:0.1:0.2:2:2:2:2.
as a further preferred embodiment, the reaction time is 24 h; the reaction temperature is 60-100 ℃; a more preferred reaction temperature is 60 ℃. The higher the temperature, the more readily the starting chloroformate will degrade, resulting in a reduced final yield.
As a further preferred embodiment, the organic solvent is toluene; the inert gas is nitrogen.
The beneficial effects of the invention are as follows: (1) The process for preparing the polysubstituted aryl carboxylic ester compound is simple to operate and mild in condition, and chloroformate is stable under the condition of the reaction system;
(2) The commercially-available aryl iodide and terminal olefin used for preparing the polysubstituted aryl carboxylate compound can be simply synthesized by adopting the existing mature process, has high safety, and avoids the preparation process of complex raw materials;
(3) The method has high atom economy in the process of preparing the polysubstituted aryl carboxylic ester compound, reduces the production cost and is beneficial to environmental protection;
(4) The method for preparing the polysubstituted aryl carboxylic ester compound has less side reaction and the yield reaches 32-90%;
(5) The method for preparing the polysubstituted aryl carboxylate compound is not limited by substrates, so that a polysubstituted aryl carboxylate library is established, and a raw material source is provided for drug screening and new drug synthesis.
Detailed Description
The conception, specific structure, and technical effects produced by the present invention will be clearly and completely described in connection with the embodiments below to fully understand the objects, aspects, and effects of the present invention.
The synthesis method comprises the following steps:
。
the method comprises the following specific steps:
palladium acetate (0.03 mmol,0.1 eq), tris (5-methoxy-1-indolyl) phosphine (0.06 mmol,0.2 eq) and Cs were added sequentially to the reaction flask 2 CO 3 (0.6 mmol,3 eq.) after nitrogen was replaced three times, 3 mL toluene, aryl iodide (0.3 mmol,1 eq.), chloroformate (0.6 mmol,2 eq.), alkene (0.6 mmol,2 eq.), 2-cyano-5-norbornene (0.6 mmol,2 eq.) and water (0.6 mmol,2 eq.) were added sequentially under nitrogen, stirred at 60 ℃ for 24 hours, after the reaction was completed, the mixture was cooled to room temperature, the reaction mixture was filtered with celite, the filter cake was washed with ethyl acetate, and the filtrate was concentrated and isolated by column chromatography to give the target product.
Examples 1 to 17 according to the above method, the polysubstituted aryl carboxylic ester compounds represented by the following formulas 1 to 17 can be prepared by changing the types of aryl iodide compound substrates and keeping other conditions unchanged:。
example 1
A substrate:;
compound 1:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (64.3 mg,70% yield); 1H NMR (400 MHz, CHCl 3) delta 8.06 (d, J=16.2 Hz, 1H), 7.68 (dd, J=7.6, 1.5 Hz, 1H), 7.38 (d, J=6.2 Hz, 3H), 7.32 (t, J=7.6 Hz, 1H), 5.90 (d, J=16.1 Hz, 1H), 4.25 (q, J=7.1 Hz, 2H), 4.02 (d, J=6.6 Hz, 2H), 2.69 (q, J=7.5 Hz, 2H), 2.05-1.95 (M, 1H), 1.32 (t, J=7.1 Hz, 3H), 1.17 (t, J=7.6 Hz, 3H), 0.96 (d, J=6. Hz, 6H), 13C {1H (100 MHz, 3.6.6 Hz, 2H), 2.37 (q, J=7.15, 2H), 2.69 (q, J=7.5 Hz, 2H), 2.05-1.95 (M, 1H), 1.7.3H), 1.1.35 (t, 1.35, 3H), 1.35 (t, 3H), 1.96 (j=7.37, 37, 37.143, 3H), 0.143, 37.143, 37, 37.35 (37H), 1.15+3.15, 37, 37.15, 37.15+3H, 37.15.15, 37.15.13, 37, 37.15.13.15.g.
Example 2
A substrate:;
compound 2:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (64.3 mg,70% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.06 (d,J=16.2 Hz, 1H), 7.68 (dd,J= 7.6, 1.5 Hz, 1H), 7.38 (d,J= 6.2Hz, 1H), 7.32 (t,J= 7.6 Hz, 1H), 5.90 (d,J= 16.1 Hz, 1H),4.25 (q,J= 7.1 Hz, 2H), 4.02 (d,J= 6.6 Hz, 2H), 2.69 (q,J= 7.5 Hz, 2H), 2.05 – 1.95 (m, 1H), 1.32 (t,J= 7.1 Hz, 3H), 1.17 (t,J= 7.6 Hz, 3H), 0.96 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 168.2, 166.3, 144.0, 143.1, 135.2, 132.1,131.3, 128.3, 127.7, 123.5, 71.63, 60.6, 27.8, 26.6, 19.3, 15.4, 15.4, 14.4;HRMS(ESI): m/z calcd for C 18 H 24 NaO 4 + [M+Na] + 327.1567 found 327.1560。
example 3
A substrate:;
compound 3:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (68.7 mg,75% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.08 (d,J=16.2 Hz, 1H), 7.63 (d,J= 7.9 Hz, 1H), 7.17 (d,J= 7.9 Hz, 1H),5.83 (d,J= 16.2 Hz, 1H), 4.25 (d,J= 7.2 Hz, 2H), 4.00 (d,J= 6.6 Hz, 2H), 2.28 (d,J= 35.0 Hz, 6H), 2.05 – 1.95 (m, 1H), 1.32 (t,J= 7.1 Hz, 3H), 0.96 (d,J= 6.7 Hz, 6H); 1313 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 167.9, 166.3, 145.3, 141.6, 136.2, 135.2,129.5, 128.7, 127.5, 123.6, 123.6, 71.4, 60.5, 27.8, 21.0, 19.3, 17.0, 14.4;HRMS(ESI): m/z calcd for C 18 H 24 NaO 4 + [M+Na] + 327.1567 found 327.1576。
example 4
A substrate:;
compound 4:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.4), brown oil (71.3 mg,78% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.00 (d,J=16.2 Hz, 1H), 7.49 (s, 1H), 7.18 (d,J= 1.8 Hz, 1H), 5.90 (d,J= 16.3 Hz, 1H), 4.25 (q,J= 7.1 Hz, 2H), 4.03 (d,J= 6.6 Hz,2H), 2.34 (d,J= 5.5 Hz, 6H), 2.07 – 1.96 (m, 1H), 1.32 (t,J=7.1 Hz, 3H), 0.97 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 168.4, 166.5, 144.0, 138.2, 137.0, 134.7,132.6, 131.4, 128.4, 123.4, 71.7, 60.6, 27.8, 21.1, 20.9, 19.4, 14.4;HRMS(ESI): m/z calcd for C 18 H 24 NaO 4 + [M+Na] + 327.1567 found 327.1557。
example 5
A substrate:;
compound 5:;
product characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (66.8 mg,61% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.10 (d,J=16.1 Hz, 1H), 7.66 (dd,J= 7.7, 1.4 Hz, 1H), 7.47 (dd,J= 7.9,1.4 Hz, 1H), 7.36 (t,J= 7.7 Hz, 1H), 5.86 (d,J= 16.1 Hz, 1H),4.25 (q,J= 7.2 Hz, 2H), 4.01 (d,J= 6.6 Hz, 2H), 3.24 – 3.18(m, 1H), 2.03 – 1.03 (m, 1H), 1.32 (t,J= 7.1 Hz, 3H), 1.20 (d,J= 6.9 Hz, 6H), 0.96 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 168.3, 166.2, 147.7, 144.4, 134.6, 131.2,128.9, 128.4, 127.5, 123.6, 71.6, 60.7, 29.8, 27.8, 23.9, 19.3, 14.4;HRMS(ESI): m/z calcd for C 19 H 26 NaO 4 + [M+Na] + 341.1723 found 341.1722。
example 6
A substrate:
compound 6:;
characterization data of the product compounds: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.4), colorless oil (91.5 mg, 87% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 7.90(d,J= 16.2 Hz, 1H), 7.78 (dd,J= 7.2, 1.9 Hz, 1H), 7.48 – 7.31(m, 5H), 7.28 – 7.23 (m, 2H), 5.66 (d,J= 16.3 Hz, 1H), 4.13 (q,J= 7.1 Hz, 2H), 4.06 (d,J= 6.7 Hz, 2H), 2.07 – 1.97 (m, 1H), 1.22 (t,J= 7.1 Hz, 3H), 0.97 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 168.5, 166.1, 143.5, 142.7, 140.2, 134.1,133.6, 132.2, 129.8, 128.9, 128.4, 127.6, 124.5, 71.9, 60.5, 27.8, 19.3, 14.3;HRMS(ESI): m/z calcd for C 22 H 24 NaO 4 + [M+Na] + 375.1567 found 375.1560。
example 7
A substrate:
compound 7:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (66.8 mg,61% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 7.94 (d,J=16.3 Hz, 1H), 7.83 (dd,J= 6.9, 2.1 Hz, 1H), 7.47 – 7.41 (m, 2H), 6.24(d,J= 16.3 Hz, 1H), 4.26 (q,J= 7.1 Hz, 2H), 4.09 (d,J= 6.6 Hz, 2H), 2.08 – 2.01 (m, 1H), 1.33 (t,J= 7.1 Hz, 3H), 0.98 (d,J= 6.7 Hz, 6H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 )δ 166.5, 166.2, 147.1, 137.6, 133.3, 129.8, 129.6, 128.8, 125.7, 124.6, 120.44(q,J= 259.0 Hz), 72.2, 60.8, 27.8, 19.3, 14.4; 19 F{ 1 H}NMR(376 MHz, CDCl 3 ) δ -57.1;HRMS (ESI):m/z calcd for C 17 H 19 F 3 NaO 5 + [M+Na] + 383.1077 found 383.1085。
example 8
A substrate:
compound 8:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), brown oil (60.1 mg,65% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.00 (d,J=16.1 Hz, 1H), 7.36 – 7.33 (m, 2H), 7.05 (dd,J= 6.9, 2.6 Hz, 1H), 6.54(d,J= 16.2 Hz, 1H), 4.23 (d,J= 7.1 Hz, 2H), 4.08 (d,J= 6.6 Hz, 2H), 3.87 (s, 3H), 2.08 – 1.98 (m, 1H), 1.31 (t,J= 7.2 Hz,3H), 0.97 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 168.1, 167.3, 158.6, 138.7, 134.0, 129.9,123.9, 123.5, 121.9, 114.0, 71.8, 60.4, 55.9, 27.8, 19.3, 14.4;HRMS (ESI):m/z calcd for C 17 H 22 NaO 5 + [M+Na] + 329.1359 found 329.1352。
example 9
A substrate:
compound 9:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (71.0 mg,68% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.07 (dd,J=16.2, 2.1 Hz, 1H), 8.00 (d,J= 7.8 Hz, 1H), 7.83 (d,J= 7.8 Hz,1H), 7.52 (t,J= 7.9 Hz, 1H), 5.92 (d,J= 16.1 Hz, 1H), 4.25(q,J= 7.1 Hz, 2H), 4.04 (d,J= 6.6 Hz, 2H), 2.04 – 1.98 (m,1H), 1.32 (t,J= 7.1 Hz, 3H), 0.97 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 166.9, 165.6, 141.0, 135.7 (d,J=1.8 Hz), 133.2, 133.1, 129.6 (q,J= 30.40 Hz), 129.0 (q,J= 5.3Hz), 128.3, 125.2 (d,J= 2.1 Hz), 123.6 (q,J= 274.2 Hz), 72.2,60.9, 27.8, 19.3, 14.3; 19 F{ 1 H}NMR(376 MHz, CDCl 3 ) δ -58.1;HRMS (ESI):m/z calcd for C 17 H 19 F 3 NaO 4 + [M+Na] + 367.1128 found 367.1137。
example 10
A substrate:;
compound 10:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.5), colorless oil (31.3 mg, 33% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 7.94(d,J= 16.3 Hz, 1H), 7.73 (dd,J= 7.8, 1.3 Hz, 1H), 7.56 (dd,J= 8.1, 1.3 Hz, 1H), 7.33 (t,J= 7.9 Hz, 1H), 6.12 (d,J= 16.3Hz, 1H), 4.26 (q,J= 7.1 Hz, 2H), 4.05 (d,J= 6.6 Hz, 2H), 2.06– 1.96 (m, 1H), 1.33 (t,J= 7.1 Hz, 3H), 0.97 (d,J= 6.7 Hz,6H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 )δ 167.1, 166.0, 140.9, 134.5, 134.2, 133.2, 133.1, 129.3, 128.6, 125.5, 72.1,60.8, 27.8, 19.3, 14.4;HRMS (ESI): m/z calcd for C 16 H 19 ClNaO 4 + [M+Na] + 333.0864 found 333.0872。
example 11
A substrate:;
compound 11:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.4), yellow oil (83.6 mg,90% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.00 (d,J=16.3 Hz, 1H), 7.78 (dd,J= 8.7, 5.6 Hz, 1H), 7.04 (t,J= 8.7Hz, 1H), 5.88 (d,J= 16.3 Hz, 1H), 4.25 (q,J= 7.1 Hz, 2H),4.02 (d,J= 6.7 Hz, 2H), 2.24 (d,J= 2.6 Hz, 3H), 2.06 – 1.96(m, 1H), 1.32 (t,J= 7.1 Hz, 3H), 0.96 (d,J= 6.8 Hz, 6H); 13 C{ 1 H} NMR(100 MHz,CHCl 3 ) δ 166.8, 166.1, 163.4 (d,J= 251.3 Hz), 143.2 (d,J= 2.5 Hz), 139.2 (d,J= 5.5 Hz), 129.8 (d,J= 10.0 Hz), 126.6(d,J= 3.4 Hz), 124.4, 124.3 (d,J= 17.4 Hz), 114.7 (d,J= 23.8 Hz), 71.7, 60.8, 27.8, 19.3, 14.4, 12.3 (d,J= 5.5 Hz); 19 F{ 1 H}NMR(376 MHz, CDCl 3 ) δ -107.7;HRMS (ESI):m/z calcd for C 17 H 21 FNaO 4 + [M+Na] + 331.1316 found 331.1313。
example 12
A substrate:;
compound 12:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.5), colorless oil (78.5 mg, 81% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.02(d,J= 16.2 Hz, 1H), 7.66 (d,J= 8.4 Hz, 1H), 7.39 (d,J= 8.4 Hz, 1H), 5.85 (d,J= 16.3 Hz, 1H), 4.26 (q,J= 7.1 Hz,2H), 4.02 (d,J= 6.6 Hz, 2H), 2.38 (s, 3H), 2.07 – 1.93 (m, 1H), 1.32(t,J= 7.1 Hz, 3H), 0.96 (d,J= 6.7 Hz, 6H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 167.1, 166.0, 143.9, 139.1, 138.1, 134.9,129.5, 128.9, 128.6, 124.5, 71.8, 60.8, 27.8, 19.3, 18.0, 14.4;HRMS (ESI):m/z calcd for C 17 H 21 ClNaO 4 + [M+Na] + 347.1021 found 347.1022。
example 13
A substrate:;
compound 13;
Compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), brown oil (74.1 mg,74% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.54 (s, 1H), 8.23 (s,1H), 8.00 (d,J= 16.3 Hz, 1H), 5.96 (d,J= 16.3 Hz, 1H), 4.27(q,J= 7.1 Hz, 2H), 4.09 (d,J= 6.7 Hz, 2H), 2.47 (s, 3H), 2.10– 2.00 (m, 1H), 1.33 (t,J= 7.1 Hz, 3H), 0.98 (d,J= 6.7 Hz,6H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 )δ 165.9, 165.6, 147.0, 142.3, 141.9, 139.3, 132.5, 127.8, 125.3, 122.9, 72.4,61.1, 27.8, 21.3, 19.3, 14.4;HRMS (ESI): m/z calcd for C 17 H 22 NO 6 + [M+H] + 336.1442 found 336.1443。
example 14
A substrate:;
compound 14:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), brown oil (92.1 mg,88% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.34 (d,J= 1.8Hz, 1H), 8.04 – 8.00 (m, 2H), 5.94 (d,J= 16.3 Hz, 1H), 4.26 (q,J= 7.1 Hz, 2H), 4.06 (d,J= 6.7 Hz, 2H), 3.93 (s, 3H), 2.40 (s, 3H),2.08 – 1.98 (m, 1H), 1.32 (t,J= 7.1 Hz, 3H), 0.97 (d,J= 6.8Hz, 6H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 )δ 167.2, 166.1, 166.0, 143.1, 140.2, 137.6, 134.5, 131.6, 129.7, 128.9, 124.5,72.0, 60.8, 52.5, 27.8, 21.0, 19.3, 14.4;HRMS (ESI): m/z calcd for C 19 H 24 NaO 6 + [M+Na] + 371.1465 found 371.1461。
example 15
A substrate:;/>
compound 15:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.5), colorless oil (57.8 mg, 51% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.01 –7,96 (m, 2H), 7.82 (d,J= 2.2 Hz, 1H), 5.92 (d,J= 16.2 Hz,1H), 4.26 (q,J= 7.1 Hz, 2H), 4.05 (d,J= 6.7 Hz, 2H), 2.07 –1.97 (m, 1H), 1.32 (t,J= 7.1 Hz, 3H), 0.97 (d,J= 6.7 Hz, 6H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 ) δ165.7, 165.4, 139.8, 134.7, 134.6, 134.0, 133.2, 131.2 (q,J= 31.0 Hz),129.3 (q,J= 5.6 Hz), 125.8, 122.8 (q,J= 274.5 Hz), 72.6,61.0, 27.8, 19.3, 14.3; 19 F{ 1 H}NMR(376 MHz, CDCl 3 ) δ -58.5;HRMS (ESI):m/z calcd for C 17 H 18 ClF 3 NaO 4 + [M+Na] + 401.0738 found 401.0730。
example 16
A substrate:;
compound 16:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.2), pale yellow oil (36.8 mg, 32% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.08(d,J= 16.2 Hz, 1H), 7.98 (d,J= 8.5 Hz, 1H), 7.47 (d,J= 8.5 Hz, 1H), 6.04 (d,J= 16.2 Hz, 1H), 4.23 (q,J= 7.1 Hz,2H), 4.07 (dd,J= 9.1, 6.6 Hz, 4H), 2.08 – 1.97 (m, 2H), 1.30 (t,J= 7.1 Hz, 3H), 0.99 – 0.96 (m, 12H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 166.2, 165.6, 165.6, 142.3, 136.6, 135.5,134.8, 132.3, 129.6, 128.70, 124.0, 72.6, 72.2, 60.8, 27.8, 27.7, 19.3, 19.3,14.4;HRMS (ESI): m/z calcd for C 21 H 27 ClNaO 6 + [M+Na] + 433.1388 found 433.1391。
example 17
A substrate:;
compound 17:
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), pale yellow oil (46.9 mg, 42% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.30(d,J= 16.0 Hz, 1H), 7.96 (d,J= 7.8 Hz, 2H), 7.46 (t,J= 7.8 Hz, 1H), 5.80 (d,J= 16.1 Hz, 1H), 4.22 (q,J= 7.1 Hz,2H), 4.03 (d,J= 6.6 Hz, 4H), 2.06 – 1.77 (m, 2H), 1.30 (t,J=7.1 Hz, 3H), 0.96 (d,J= 6.8 Hz, 12H), 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 167.3, 165.8, 144.7, 137.1, 132.9, 132.3,128.3, 122.6, 72.0, 60.6, 27.8, 19.3, 14.4;HRMS (ESI): m/z calcd for C 21 H 28 NaO 6 + [M+Na] + 399.1778 found 399.1784。
examples 18 to 33 according to the above method, the polysubstituted aryl carboxylic ester compounds represented by the following formulas 18 to 33 can be prepared by changing the types of chloroformate compound substrates and keeping the other conditions unchanged:。
example 18
A substrate:;
compound 18:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.3), pale yellow solid (71.3 mg,73% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.42 (d,J= 16.2 Hz, 1H), 8.17 (d,J= 8.6 Hz, 1H), 7.95 (d,J= 8.7 Hz, 1H), 7.88 – 7.84 (m, 2H), 7.60 – 7.52 (m, 2H), 6.08 (d,J=16.2 Hz, 1H), 4.35 – 4.30 (m, 4H), 1.77 – 1.72 (m, 2H), 1.49 – 1.44 (m, 2H),1.37 (t,J= 7.1 Hz, 3H), 0.97 (t,J= 7.4 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.7, 166.3, 143.5, 136.0, 135.1,131.0, 128.6, 128.4, 128.0, 127.3, 127.2, 126.8, 125.7, 125.2, 65.5, 60.8,30.7, 19.4, 14.4, 13.8;HRMS (ESI): m/z calcd for C 20 H 22 NaO 4 + [M+Na] + 349.1410, found 349.1410。
example 19
A substrate:;
compound 19:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=50:1, rf=0.2), yellow oil (71.9 mg,65% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.42 (d,J= 16.2Hz, 1H), 8.17 (d,J= 8.1 Hz, 1H), 7.95 (d,J= 8.6 Hz, 1H), 7.87– 7.84 (m, 2H), 7.59 – 7.51 (m, 2H), 6.08 (d,J= 16.2 Hz, 1H), 4.35 –4.30 (m, 4H), 1.80 – 1.73 (m, 2H), 1.42 – 1.29 (m, 11H), 0.89 (t,J=6.7 Hz, 3H); 13 C{ 1 H} NMR(100 MHz, CDCl 3 )δ167.6, 166.2, 143.5, 136.1, 135.1, 131.0, 128.6, 128.3, 128.0, 127.3,127.1, 126.8, 125.7, 125.1, 65.8, 60.8, 31.8, 29.1, 28.7, 26.1, 22.7, 14.4,14.1;HRMS (ESI): m/z calcd for C 23 H 28 NaO 4 + [M+Na] + 391.1880 found 391.1876。
example 20
A substrate:;
compound 20:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.4), pale yellow oil (77.3 mg, 82% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.41 (d,J= 16.2 Hz, 1H), 8.15 (d,J= 7.8 Hz, 1H),7.92 (d,J= 8.6 Hz, 1H), 7.87 – 7.83 (m, 2H), 7.58 – 7.51 (m, 2H), 6.08(d,J= 16.2 Hz, 1H), 5.33 -5.23 (m, 1H), 4.33 (q,J= 7.1 Hz,2H), 1.37 (d,J= 6.0 Hz, 8H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.2, 166.2, 143.5, 135.6, 135.0,131.00, 128.6, 128.3, 127.9, 127.8, 127.1, 126.7, 125.7, 125.1, 69.2, 60.7,21.9, 14.4;HRMS (ESI): m/z calcd for C 19 H 20 NaO 4 + [M+Na] + 335.1254 found 335.1248。
example 21
A substrate:;/>
compound 21:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.2), colorless oil (71.3 mg,73% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.42(d,J= 16.2 Hz, 1H), 8.16 (d,J= 1.6 Hz, 1H), 7.94 (d,J= 8.7 Hz, 1H), 7.87 – 7.84 (m, 2H), 7.59 – 7.51 (m, 2H), 6.09 (d,J=16.3 Hz, 1H), 5.17 – 5.10 (m,J= 6.3 Hz, 1H), 4.33 (q,J= 7.2Hz, 2H), 1.80 -1.73 (dt,J= 14.3, 7.1 Hz, 1H), 1.70 – 1.61 (m, 1H),1.39 – 1.34 (m, 6H), 0.97 (t,J= 7.5 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.3, 166.2, 143.6, 135.6, 135.0,131.0, 128.6, 128.3, 127.9, 127.8, 127.1, 126.7, 125.7, 125.2, 73.8, 60.7,28.9, 19.5, 14.4, 9.8;HRMS (ESI): m/z calcd for C 20 H 22 NaO 4 + [M+Na] + 349.1410 found 349.1402。
example 22
A substrate:;
compound 22:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), pale yellow oil (90.3 mg, 83% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.43 (d,J= 16.3 Hz, 1H), 8.18 (d,J= 8.2 Hz, 1H),7.97 (d,J= 8.6 Hz, 1H), 7.89 – 7.85 (m, 2H), 7.60 – 7.52 (m, 2H), 6.09(d,J= 16.3 Hz, 1H), 4.32 (q,J= 7.2 Hz, 2H), 4.12 (d,J= 6.6 Hz, 2H), 2.13 – 2.03 (m, 1H), 1.37 (t,J= 7.1 Hz, 3H), 1.02 (d,J= 6.7 Hz, 6H); 13 C{ 1 H} NMR(100 MHz, CDCl 3 )δ167.6, 166.3, 143.5, 136.1, 135.2, 131.1, 128.7, 128.4, 128.0, 127.3,127.2, 126.8, 125.8, 125.3, 71.8, 60.8, 27.9, 19.4, 14.4;HRMS (ESI):m/z calcd for C 20 H 22 NaO 4 + [M+Na] + 349.1410 found 349.1415。
example 23
A substrate:;
compound 23:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.2), pale yellow oil (72.5 mg, 71% yieldd); 1 H NMR(400 MHz, CDCl 3 )δ8.39 (d,J= 16.2 Hz, 1H), 8.16 (d,J= 8.2 Hz, 1H),7.93 (d,J= 8.6 Hz, 1H), 7.88 – 7.84 (m, 2H), 7.60 – 7.52 (m, 2H), 6.08(d,J= 16.2 Hz, 1H), 5.46 – 5.42 (m, 1H), 4.33 (q,J= 7.1 Hz,2H), 1.96 – 1.77 (m, 6H), 1.68 – 1.61 (m, 2H), 1.37 (t,J= 7.1 Hz, 3H); 13 C{ 1 H} NMR(100 MHz, CDCl 3 )δ167.5, 166.2, 143.6, 135.7, 135.1, 131.1, 128.6, 128.4, 127.9, 127.7,127.1, 126.7, 125.9, 125.2, 78.7, 60.8, 32.8, 23.9, 14.5;HRMS (ESI): m/zcalcd for C 21 H 22 NaO 4 + [M+Na] + 361.1410 found 361.1409。
example 24
A substrate:;
compound 24:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), yellow solid (82.9 mg,62% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.51 (d,J= 16.3 Hz, 1H), 8.25 (d,J= 8.2 Hz, 1H), 7.97 (d,J= 8.7 Hz,1H), 7.91 (d,J= 7.8 Hz, 2H), 7.80 (d,J= 7.5 Hz, 2H), 7.66 (d,J= 7.6 Hz, 2H), 7.63 – 7.56 (m, 2H), 7.43 (t,J= 7.4 Hz, 2H),7.35 – 7.31 (m, 2H), 6.17 (d,J= 16.3 Hz, 1H), 4.67 (d,J= 7.2Hz, 2H), 4.40 (t,J= 7.1 Hz, 1H), 4.29 (q,J= 7.1 Hz, 2H), 1.32(t,J= 7.1 Hz, 3H); 13 C{ 1 H} NMR(100MHz, CDCl 3 )δ167.2, 166.2, 143.9, 143.3, 141.4, 136.7,135.3, 131.1, 128.9, 128.4, 128.2, 127.9, 127.3, 126.9, 126.7, 125.5, 125.4,125.2, 120.2, 67.5, 60.8, 47.0, 14.4;HRMS (ESI): m/z calcd for C 30 H 24 NaO 4 + [M+Na] + 471.1567 found 471.1564。
example 25
A substrate:;
compound 25:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.3), yellow oil (110.3 mg,90% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.41 (d,J=16.2 Hz, 1H), 8.16 (d,J= 8.2 Hz, 1H), 7.94 (d,J= 8.6 Hz, 1H),7.89 – 7.85 (m, 2H), 7.60 – 7.52 (m, 2H), 6.09 (d,J= 16.2 Hz, 1H),4.98 (td,J= 10.9, 4.4 Hz, 1H), 4.32 (q,J= 7.1 Hz, 2H), 217 –2.12 (m, 1H), 1.94 (td,J= 7.0, 2.8 Hz, 1H), 1.75 – 1.70 (m, 2H), 1.57– 1.50 (m, 2H), 1.38 (t,J= 7.1 Hz, 3H), 1.12 (q,J= 12.1 Hz,2H), 0.92 (dd,J= 14.5, 6.8 Hz, 7H), 0.80 (d,J= 6.9 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 167.3, 166.2, 143.6, 135.7, 135.0, 131.1,128.6, 128.4, 127.9, 127.9, 127.2, 126.8, 125.7, 125.2, 75.7, 60.8, 47.3, 41.0,34.4, 31.6, 26.5, 23.5, 22.2, 20.9, 16.4, 14.5;HRMS (ESI): m/z calcdfor C 26 H 32 NaO 4 + [M+Na] + 431.2193 found 431.2202。
example 26
A substrate:;
compound 26:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=10:1, rf=0.3), pale yellow oil (68.5 mg, 63% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.43 (d,J= 16.2 Hz, 1H), 8.18 (d,J= 8.3 Hz, 1H), 7.99 (d,J= 8.7 Hz, 1H), 7.88 – 7.84 (m, 2H), 7.61 – 7.53 (m, 2H), 7.48 – 7.46 (m, 2H),7.42 – 7.34 (m, 3H), 6.08 (d,J= 16.2 Hz, 1H), 5.38 (s, 2H), 4.31 (q,J= 7.1 Hz, 2H), 1.37 (t,J= 7.1 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.3, 166.2, 143.4, 136.5, 135.7,135.2, 131.1, 128.72, 128.7, 128.6, 128.4, 128.4, 128.1, 127.2, 126.8, 126.8,125.8, 125.3, 67.4, 60.8, 14.4;HRMS (ESI): m/z calcd for C 23 H 21 O 4 + [M+H] + 361.1434 found 361.1444。
example 27
A substrate:;
compound 27:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.4), yellow oil (68.1 mg, 60% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.40 (d,J= 16.2Hz, 1H), 8.16 (d,J= 8.3 Hz, 1H), 7.95 (d,J= 8.7 Hz, 1H), 7.87– 7.83 (m, 2H), 7.60 – 7.52 (m, 2H), 7.46 – 7.42 (m, 2H), 7.07 (t,J=8.7 Hz, 2H), 6.05 (d,J= 16.2 Hz, 1H), 5.33 (s, 2H), 4.31 (q,J= 7.1 Hz, 2H), 1.36 (t,J= 7.2 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.2, 166.1, 162.8 (d,J=247.0 Hz), 143.2, 136.4, 135.2, 131.6 (d,J= 3.3 Hz), 131.0, 130.6 (d,J= 8.2 Hz), 128.7, 128.4, 128.1, 127.2, 126.8, 126.7, 125.7, 125.4, 115.6 (d,J= 21.6 Hz), 66.6, 60.8, 14.38; 19 F{ 1 H}NMR(376 MHz, CDCl 3 )δ-113.4;HRMS(ESI): m/z calcd for C 23 H 20 FO 4 + [M+H] + 379.1340 found 379.1347。
example 28
A substrate:;
compound 28:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=15:1, rf=0.2), brown oil (56.4 mg,44% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.34 (d,J=16.2 Hz, 1H), 8.10 (d,J= 8.5 Hz, 1H), 7.91 (d,J= 8.6 Hz, 1H),7.82 –7.79 (m, 2H), 7.59 – 7.4 (m, 6H), 6.00 (d,J= 16.3 Hz, 1H), 5.34(s, 2H), 4.21 (d,J= 7.1 Hz, 2H), 1.27 (t,J= 7.1 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ167.11, 166.15, 143.29,139.74, 136.72, 135.34, 131.07, 130.59 (q,J= 32.5 Hz), 128.81, 128.55,128.43, 128.33, 127.36, 126.91, 126.31, 125.73 (q,J= 3.9 Hz), 125.68,125.49, 121.43 (q,J= 272.3 Hz), 66.40, 60.88, 14.40; 19 F{ 1 H}NMR(376 MHz, CDCl 3 ) δ -62.6;HRMS (ESI):m/z calcd for C 24 H 19 F 3 NaO 4 + [M+Na] + 451.1128 found 451.1119。
example 29
A substrate:;
compound 29:;
compound characterization data: purified by flash columnchromatography (petroleum ether/AcOEt = 15:1, rf = 0.2), yellow oil (87.7 mg,74% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.43 (d,J= 16.3 Hz,1H), 8.18 (d,J= 8.3 Hz, 1H), 8.01 (d,J= 8.6 Hz, 1H), 7.89 –7.85 (m, 2H), 7.61 – 7.51 (m, 3H), 7.44 – 7.40 (m, 1H), 7.32 – 7.25 (m, 2H),6.09 (d,J= 16.3 Hz, 1H), 5.48 (s, 2H), 4.30 (q,J= 7.1 Hz,2H), 1.36 (t,J= 7.1 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CHCl 3 ) δ 167.0, 166.1, 143.2, 136.7, 135.3, 134.1,133.5, 131.1, 130.3, 129.8, 129.8, 128.7, 128.4, 128.2, 127.2, 127.1, 126.9,126.5, 125.8, 125.5, 64.7, 60.8, 14.4;HRMS (ESI): m/z calcd for C 23 H 19 ClNaO 4+ [M+Na] + 417.0864 found 417.0873。
Example 30
A substrate:;
compound 30:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=5:1, rf=0.2), yellow oil (57.0 mg,49% yield); 1 H NMR(400 MHz, CHCl 3 ) δ 8.40 (d,J= 16.2Hz, 1H), 8.17 (d,J= 8.5 Hz, 1H), 7.98 (d,J= 8.7 Hz, 1H), 7.90– 7.87 (m, 2H), 7.68 (d,J= 8.3 Hz, 2H), 7.62 – 7.55 (m, 4H), 6.07 (d,J= 16.3 Hz, 1H), 5.41 (s, 2H), 4.30 (q,J= 7.2 Hz, 2H), 1.35 (t,J= 7.1 Hz, 3H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 )δ 167.0, 166.1, 143.2, 141.1, 136.8, 135.4, 132.6, 131.1, 128.9, 128.7, 128.4,128.4, 127.4, 126.9, 126.2, 125.6, 125.5, 118.7, 112.3, 66.2, 60.9, 14.4;HRMS(ESI): m/z calcd for C 24 H 19 NNaO 4 + [M+Na] + 408.1206 found 408.1193。
example 31
A substrate:;
compound 31:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=5:1, rf=0.3), white solid (52.7 mg,43% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.41 (d,J= 16.3 Hz, 1H), 8.25 (d,J= 8.8 Hz, 2H), 8.17 (d,J= 8.4 Hz,1H), 7.99 (d,J= 8.7 Hz, 1H), 7.90 – 7.88 (m, 2H), 7.63 – 7.55 (m, 4H),6.07 (d,J= 16.3 Hz, 1H), 5.46 (s, 2H), 4.29 (q,J= 7.1 Hz,2H), 1.35 (t,J= 7.1 Hz, 3H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.0, 166.1, 147.9, 148.0, 143. 2,143.2, 143.0, 136.8, 135.4, 131.1, 128.9, 128. 4, 127.4, 126.9, 126.1, 125.6,124.0, 65.9, 60.9, 14.4;HRMS (ESI): m/z calcd for C 23 H 19 NNaO 6 + [M+Na] + 428.1105 found 428.1107。
example 32
A substrate:;/>
compound 32:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=5:1, rf=0.3), yellow oil (82.9 mg,66% yield); 1 H NMR(400 MHz, CHCl 3 )δ8.41 (d,J= 16.3 Hz, 1H), 8.17 (d,J= 8.5 Hz, 1H), 8.06 (d,J= 8.4 Hz,2H), 7.99 (d,J= 8.7 Hz, 1H), 7.89 – 7.86 (m, 2H), 7.62 – 7.55 (m, 2H),7.51 (d,J= 8.3 Hz, 2H), 6.07 (d,J= 16.3 Hz, 1H), 5.42 (s,2H), 4.29 (q,J= 7.1 Hz, 2H), 3.92 (s, 3H), 1.34 (t,J= 7.1 Hz,3H); 13 C{ 1 H} NMR(100 MHz, CHCl 3 )δ167.1, 166.9, 166.2, 143.2, 140.8, 136.7, 135.3, 131.1, 130.2, 130.1,128.8, 128.4, 128.3, 128.1, 127.3, 126.9, 126.5, 125.7, 125.5, 66.6, 60.9,52.3, 14.4;HRMS (ESI): m/z calcd for C 25 H 22 NaO 6 + [M+Na] + 441.1309 found 441.1310。
example 33
A substrate:;
compound 33:;
compound characterization data: purified by flash columnchromatography (petroleum ether/acoet=25:1, rf=0.2), pale yellow oil (66.8 mg, 53% yield); 1 H NMR(400 MHz, CDCl 3 )δ8.46 (d,J= 16.3 Hz, 1H), 8.19 (d,J= 7.8 Hz, 1H),8.00 (d,J= 8.6 Hz, 1H), 7.86 (t,J= 8.9 Hz, 2H), 7.61 – 7.53(m, 2H), 7.45 – 7.40 (m, 4H), 6.11 (d,J= 16.3 Hz, 1H), 5.36 (s, 2H),4.34 (q,J= 7.1 Hz, 2H), 1.40 – 1.35 (m, 12H); 13 C{ 1 H}NMR(100 MHz, CDCl 3 )δ167.3, 166.2, 151.5, 143.4, 136.5,135.2, 132.8, 131.1, 128.6, 128.4, 128.4, 128.1, 127.2, 126.9, 126.8, 125.8,125.6, 125.3, 67.2, 60.8, 34.7, 31.4, 14.4;HRMS (ESI): m/z calcd for C 27 H 28 NaO 4 + [M+Na] + 439.1880 found 439.1887。
furthermore, we have attempted to use other reaction systems:
comparative example 1
The palladium acetate in example 22 was removed, reacted for 24 hours, suction filtered, and the solvent was distilled off under reduced pressure, and other conditions were kept unchanged, whereby the objective poly-substituted aryl carboxylate could not be obtained.
Comparative example 2
The ethyl acrylate in example 22 was removed, reacted for 24 hours, suction filtered, and the solvent was distilled off under reduced pressure, and other conditions were kept unchanged, so that the objective poly-substituted aryl carboxylate could not be obtained.
Comparative example 3
The tris (5-methoxy-1-indolyl) phosphine reagent of example 22 was replaced with tris (4-methoxyphenyl) phosphine reagent (0.6 mmol,0.2 equiv), reacted for 24 hours, suction filtered, the solvent was distilled off under reduced pressure, other conditions were kept unchanged, and the product compound 24 was obtained in 12% yield by flash column chromatography.
Comparative example 4
The water in example 22 was removed, the solvent toluene reagent was changed to an N, N-dimethylformamide reagent, and the reaction was carried out for 24 hours, suction filtration and distillation under reduced pressure were carried out to remove the solvent, and other conditions were kept unchanged, whereby the objective polysubstituted aryl carboxylate could not be obtained.
While the present invention has been described in considerable detail and with particularity with respect to several described embodiments, it is not intended to be limited to any such detail or embodiments or any particular embodiment, but is to be construed as providing broad interpretation of such claims by reference to the appended claims in view of the prior art so as to effectively encompass the intended scope of the invention. Furthermore, the foregoing description of the invention has been presented in its embodiments contemplated by the inventors for the purpose of providing a useful description, and for the purposes of providing a non-essential modification of the invention that may not be presently contemplated, may represent an equivalent modification of the invention.
Claims (10)
1. The preparation method of the polysubstituted aryl carboxylic ester compound is characterized by comprising the following steps:
cesium carbonate, palladium acetate and tris (5-methoxy-1-indolyl) phosphine are replaced by nitrogen for three times, then an organic solvent is added, then aryl iodide, water, chloroformate, ethyl acrylate and 2-cyano-5-norbornene are sequentially added, and the mixture is reacted under the protection of inert gas for 12 h-48 h, and after the reaction is finished, the organic solvent is removed and purified, so that the polysubstituted aryl carboxylate compound is obtained; the structural formula of the aryl iodide is shown as a formula I; the structural formula of the polysubstituted aryl carboxylic ester compound is shown in a formula II;
a formula I; />A formula II; wherein R is 1 ,R 2 Are each independently selected from aryl or alkyl.
2. The process of claim 1, wherein R is 1 At least one selected from methyl, ethyl, isopropyl, phenyl, oxytrifluoromethyl, methoxy, trifluoromethyl, halogen, nitro and alkoxycarbonyl.
3. The process of claim 1, wherein R is 2 Selected from butyl, heptyl, isopropyl, sec-butyl, isobutyl, cyclopentyl, 9-fluorenylmethoxycarbonyl, [1S- (1. Alpha., 2. Alpha., 5. Beta.)]-at least one of 5-methyl-2- (1-methylethyl) cyclohexyl, benzyl, 4-fluorobenzyl, 4-trifluoromethylbenzyl, 2-chlorobenzyl, 4-cyanobenzyl, 4-nitrobenzyl, 4-methoxybenzyl, 4-t-butylbenzyl.
4. The preparation method according to claim 1, wherein the molar ratio of the aryl iodide compound, cesium carbonate, palladium acetate, tris (5-methoxy-1-indolyl) phosphine, water, chloroformate, olefin and 2-cyano-5-norbornene is 1:3:0.1:0.2:2:2:2:2.
5. the method of claim 1, wherein the reaction time is 24 h.
6. The process according to claim 1, wherein the reaction temperature is from 60 ℃ to 100 ℃.
7. The process of claim 6, wherein the reaction temperature is 60 ℃.
8. The method according to claim 1, wherein the organic solvent is toluene.
9. The method according to claim 1, wherein the inert gas is nitrogen.
10. A process according to any one of claims 1 to 9, wherein the polysubstituted aryl carboxylate compound has the structure as described in any one of the following compounds 1 to 33:
。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310458655.2A CN117185925B (en) | 2023-04-26 | 2023-04-26 | Preparation method of polysubstituted aryl carboxylate compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310458655.2A CN117185925B (en) | 2023-04-26 | 2023-04-26 | Preparation method of polysubstituted aryl carboxylate compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117185925A true CN117185925A (en) | 2023-12-08 |
CN117185925B CN117185925B (en) | 2024-04-26 |
Family
ID=88991268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310458655.2A Active CN117185925B (en) | 2023-04-26 | 2023-04-26 | Preparation method of polysubstituted aryl carboxylate compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117185925B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016013976A1 (en) * | 2014-07-23 | 2016-01-28 | Nanyang Technological University | Method of forming a multi-substituted benzene compound |
CN108503549A (en) * | 2018-03-26 | 2018-09-07 | 江西师范大学 | Aromatic carboxylic acid trifluoroethyl ester type compound and preparation method thereof |
CN115739184A (en) * | 2022-09-27 | 2023-03-07 | 成都欣华源科技有限责任公司 | Diisobutylene hydroformylation catalyst composition and application thereof |
-
2023
- 2023-04-26 CN CN202310458655.2A patent/CN117185925B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016013976A1 (en) * | 2014-07-23 | 2016-01-28 | Nanyang Technological University | Method of forming a multi-substituted benzene compound |
CN108503549A (en) * | 2018-03-26 | 2018-09-07 | 江西师范大学 | Aromatic carboxylic acid trifluoroethyl ester type compound and preparation method thereof |
CN115739184A (en) * | 2022-09-27 | 2023-03-07 | 成都欣华源科技有限责任公司 | Diisobutylene hydroformylation catalyst composition and application thereof |
Non-Patent Citations (3)
Title |
---|
DING, YA-NAN 等: "Palladium-Catalyzed ortho-C−H Glycosylation/ipso-Alkenylation of Aryl Iodides", 《J. ORG. CHEM. 》, vol. 85, no. 17, 31 December 2000 (2000-12-31), pages 11280 * |
WU, ZHAO 等: "Distal Alkenyl C-H Functionalization via the Palladium/Norbornene Cooperative Catalysis", 《J. AM. CHEM. SOC.》, vol. 142, 31 December 2000 (2000-12-31), pages 2715 * |
YUNZE HUANG 等: "Palladium-Catalyzed Catellani ortho-Acylation Reaction: An Efficient and Regiospecific Synthesis of Diaryl Ketones", 《ANGEW. CHEM. INT. ED.》, vol. 54, 31 December 2015 (2015-12-31), pages 12669 * |
Also Published As
Publication number | Publication date |
---|---|
CN117185925B (en) | 2024-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69634639T2 (en) | PROCESS FOR PRODUCING OPTICAL ACTIVE COMPOUNDS | |
EP2914574B1 (en) | New process | |
WO1989006225A1 (en) | Ligand-accelerated catalytic asymmetric dihydroxylation | |
CN117185925B (en) | Preparation method of polysubstituted aryl carboxylate compound | |
AU690626B2 (en) | Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-beta -amino acids | |
CN107235887B (en) | Polysubstituted diindolylmethane derivative and preparation method thereof | |
Gonzalez-Bulnes et al. | Practical synthesis of (−)-1-amino-1-deoxy-myo-inositol from achiral precursors | |
CN116178162A (en) | Green and rapid preparation method of nitrate radical transfer reagent | |
KR100613636B1 (en) | Process for the preparation of pentaacetyl-?-d-glucopyranose | |
CN115215814A (en) | Synthetic method of isoxazolidine compounds | |
KR101769204B1 (en) | New method for preparation of chiral chromanol derivatives | |
CN110540516B (en) | Preparation method of 1-sulfonylmethyl-3, 4-dihydronaphthalene | |
CN113896662A (en) | Amino cyclopropane carboxylic acid compound and preparation method and application thereof | |
CN111362795B (en) | Preparation method of substituted butyrate derivatives | |
CN109438327B (en) | Fused ring compound and preparation method thereof | |
JP3738225B2 (en) | Novel chiral copper catalyst and method for producing N-acylated amino acid derivative using the same | |
CN112521278B (en) | Method for preparing carboxylic ester compound | |
CN115490728B (en) | Synthesis method of allyl phosphine derivative | |
CN110305025B (en) | Method for synthesizing benzylamine compound by imine catalytic hydrogenation | |
CN100338078C (en) | Process for preparing phosphorodiamidites | |
CN115260192B (en) | Nitrogen-containing condensed ring compound and synthesis method thereof | |
CN115677456B (en) | Preparation method of cannabidiol | |
CN114478355B (en) | Synthesis method of indoline derivative | |
JP3345637B2 (en) | Method for producing hydroxy compound and catalyst for producing the same | |
CN117229200A (en) | Method for synthesizing acyloxy 2-benzoyl pyridine compound by ruthenium catalysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |